Voices
Christina Annunziata
Christina Annunziata/LinkedIn

Christina Annunziata: Novel ADC Targeting Glycosylation in Ovarian Cancer

Christina Annunziata, Senior Vice President at American Cancer Society, shared a post on LinkedIn:

“Presenting exciting new data on novel ADC for ovarian cancer, from Precision Biologics, Inc., with Philip M Arlen, targeting cancer-specific glycosylation.”

More from Christina Annunziata on OncoDaily.

 

ADC American Cancer Society cancer Christina Annunziata OncoDaily Oncology Ovarian Cancer Philip M Arlen